These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
235 related items for PubMed ID: 34582425
41. Epidemiology of Vasopressin Use for Adults with Septic Shock. Vail EA, Gershengorn HB, Hua M, Walkey AJ, Wunsch H. Ann Am Thorac Soc; 2016 Oct; 13(10):1760-1767. PubMed ID: 27404213 [Abstract] [Full Text] [Related]
42. Effect of Early Administration of Vasopressin on New-Onset Arrhythmia Development in Patients With Septic Shock: A Retrospective, Observational Cohort Study. McCloskey MM, Gibson GA, Pope HE, Giacomino BD, Hampton N, Micek ST, Kollef MH, Betthauser KD. Ann Pharmacother; 2024 Jan; 58(1):5-14. PubMed ID: 37056040 [Abstract] [Full Text] [Related]
43. Vasopressin Versus Norepinephrine for the Management of Septic Shock in Cancer Patients: The VANCS II Randomized Clinical Trial. Hajjar LA, Zambolim C, Belletti A, de Almeida JP, Gordon AC, Oliveira G, Park CHL, Fukushima JT, Rizk SI, Szeles TF, Dos Santos Neto NC, Filho RK, Galas FRBG, Landoni G. Crit Care Med; 2019 Dec; 47(12):1743-1750. PubMed ID: 31609774 [Abstract] [Full Text] [Related]
44. Effect of norepinephrine on the outcome of septic shock. Martin C, Viviand X, Leone M, Thirion X. Crit Care Med; 2000 Aug; 28(8):2758-65. PubMed ID: 10966247 [Abstract] [Full Text] [Related]
45. Practice Patterns in the Initiation of Secondary Vasopressors and Adjunctive Corticosteroids during Septic Shock in the United States. Bosch NA, Teja B, Wunsch H, Walkey AJ. Ann Am Thorac Soc; 2021 Dec; 18(12):2049-2057. PubMed ID: 33975530 [Abstract] [Full Text] [Related]
46. Machine learning to predict vasopressin responsiveness in patients with septic shock. Scheibner A, Betthauser KD, Bewley AF, Juang P, Lizza B, Micek S, Lyons PG. Pharmacotherapy; 2022 Jun; 42(6):460-471. PubMed ID: 35426141 [Abstract] [Full Text] [Related]
47. Association Between Vasopressin Rebranding and Utilization in Patients With Septic Shock. Sacha GL, Kiser TH, Wright GC, Vandivier RW, Moss M, Burnham EL, Ho PM, Reynolds PM, Bauer SR. Crit Care Med; 2022 Apr 01; 50(4):644-654. PubMed ID: 34605778 [Abstract] [Full Text] [Related]
48. Vasopressin Plasma Concentrations Are Not Associated with Hemodynamic Response to Exogenous Vasopressin for Septic Shock. Yerke JR, Sacha GL, Scheraga RG, Culver DA, Abraham S, Torbic H, Lam SW, Ammar MA, Olman MA, Bauer SR. Pharmacotherapy; 2020 Jan 01; 40(1):33-39. PubMed ID: 31705703 [Abstract] [Full Text] [Related]
49. Discontinuation of Vasopressin Before Norepinephrine in the Recovery Phase of Septic Shock. Hammond DA, McCain K, Painter JT, Clem OA, Cullen J, Brotherton AL, Chopra D, Meena N. J Intensive Care Med; 2019 Oct 01; 34(10):805-810. PubMed ID: 28618919 [Abstract] [Full Text] [Related]
50. High-dose vasopressin is not superior to norepinephrine in septic shock. Klinzing S, Simon M, Reinhart K, Bredle DL, Meier-Hellmann A. Crit Care Med; 2003 Nov 01; 31(11):2646-50. PubMed ID: 14605537 [Abstract] [Full Text] [Related]
51. Vasopressin in Conjunction With Norepinephrine in Septic Shock: A Retrospective Cohort Study From a Low Middle-Income Country. Raza HA, Arshad A, Ayaz A, Raja MHR, Gauhar F, Khan M, Jamil B. Crit Care Explor; 2020 Nov 01; 2(11):e0274. PubMed ID: 33196051 [Abstract] [Full Text] [Related]
52. Vasopressin in catecholamine-resistant septic and cardiogenic shock in very-low-birthweight infants. Meyer S, Löffler G, Polcher T, Gottschling S, Gortner L. Acta Paediatr; 2006 Oct 01; 95(10):1309-12. PubMed ID: 16982509 [Abstract] [Full Text] [Related]
53. Hemodynamic Response to Vasopressin Dosage of 0.03 Units/Min vs. 0.04 Units/Min in Patients With Septic Shock. Bauer SR, Sacha GL, Lam SW, Wang L, Reddy AJ, Duggal A, Vachharajani V. J Intensive Care Med; 2022 Jan 01; 37(1):92-99. PubMed ID: 33251906 [Abstract] [Full Text] [Related]
54. Evaluation of Vasopressor Exposure and Mortality in Patients With Septic Shock. Roberts RJ, Miano TA, Hammond DA, Patel GP, Chen JT, Phillips KM, Lopez N, Kashani K, Qadir N, Cairns CB, Mathews K, Park P, Khan A, Gilmore JF, Brown ART, Tsuei B, Handzel M, Chang AL, Duggal A, Lanspa M, Herbert JT, Martinez A, Tonna J, Ammar MA, Nazer LH, Heavner M, Pender E, Chambers L, Kenes MT, Kaufman D, Downey A, Brown B, Chaykosky D, Wolff A, Smith M, Nault K, Gong MN, Sevransky JE, Lat I, Observation of VariatiOn in fLUids adMinistEred in shock-CHaracterizAtion of vaSoprEssor Requirements in Shock (VOLUME-CHASERS) Study Group and SCCM Discovery Network. Crit Care Med; 2020 Oct 01; 48(10):1445-1453. PubMed ID: 32706559 [Abstract] [Full Text] [Related]
55. Narrative Review of Controversies Involving Vasopressin Use in Septic Shock and Practical Considerations. Der-Nigoghossian C, Hammond DA, Ammar MA. Ann Pharmacother; 2020 Jul 01; 54(7):706-714. PubMed ID: 31958982 [Abstract] [Full Text] [Related]
56. Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Tsuneyoshi I, Yamada H, Kakihana Y, Nakamura M, Nakano Y, Boyle WA. Crit Care Med; 2001 Mar 01; 29(3):487-93. PubMed ID: 11373409 [Abstract] [Full Text] [Related]
57. Vasopressin compared with norepinephrine augments the decline of plasma cytokine levels in septic shock. Russell JA, Fjell C, Hsu JL, Lee T, Boyd J, Thair S, Singer J, Patterson AJ, Walley KR. Am J Respir Crit Care Med; 2013 Aug 01; 188(3):356-64. PubMed ID: 23796235 [Abstract] [Full Text] [Related]
58. Efficacy and Outcomes After Vasopressin Guideline Implementation in Septic Shock. Wu JY, Stollings JL, Wheeler AP, Semler MW, Rice TW. Ann Pharmacother; 2017 Jan 01; 51(1):13-20. PubMed ID: 27630192 [Abstract] [Full Text] [Related]
59. The effect of early vasopressin use on patients with septic shock: A systematic review and meta-analysis. Huang H, Wu C, Shen Q, Xu H, Fang Y, Mao W. Am J Emerg Med; 2021 Oct 01; 48():203-208. PubMed ID: 33975132 [Abstract] [Full Text] [Related]
60. Does body weight impact the efficacy of vasopressin therapy in the management of septic shock? Miller JT, Welage LS, Kraft MD, Alaniz C. J Crit Care; 2012 Jun 01; 27(3):289-93. PubMed ID: 21855282 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]